Nilay D Shah, PhD

  • 11280 Citations
  • 53 Scopus h-Index
19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2019

Evolution of Medicare Formulary Coverage Changes for Antithrombotic Therapies After Guideline Updates

Dayoub, E. J., Ross, J. S., Shah, N. D. & Dhruva, S. S., Oct 1 2019, In : Circulation. 140, 14, p. 1227-1230 4 p.

Research output: Contribution to journalLetter

Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States"

Siontis, K. C., Zhang, X., Schaubel, D. E., Yao, X., Noseworthy, P. A., Shah, N. D., Saran, R. & Nallamothu, B. K., Mar 19 2019, In : Circulation. 139, 12, p. 1563-1564 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Supplement Use by US Adults With CKD: A Population-Based Study

Kurani, S., Hickson, L. T. J., Thorsteinsdottir, B., Barreto, E. F., Haag, J. D., Shah, N. D. & McCoy, R. G., Dec 2019, In : American Journal of Kidney Diseases. 74, 6, p. 862-865 4 p.

Research output: Contribution to journalLetter

Open Access
2018

Medicare beneficiary out-of-pocket costs for generic cardiovascular medications available through $4 generic drug discount programs

Liu, P., Dhruva, S. S., Shah, N. D. & Ross, J. S., Dec 4 2018, In : Annals of internal medicine. 169, 11, p. 817-819 3 p.

Research output: Contribution to journalLetter

3 Scopus citations

Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA

Go, R. S., Heien, H. C., Sangaralingham, L. R., Habermann, E. B. & Shah, N. D., Feb 28 2018, In : Haematologica. 103, 3, p. e123-e125

Research output: Contribution to journalLetter

4 Scopus citations
2017

Characteristics of novel therapeutics and postmarket safety events - Reply

Downing, N. S., Shah, N. D. & Ross, J. S., Sep 19 2017, In : JAMA - Journal of the American Medical Association. 318, 11, p. 1067-1068 2 p.

Research output: Contribution to journalLetter

Medicare Formulary Changes After the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline

Dhruva, S. S., Desai, N. R., Karaca-Mandic, P., Shah, N. D. & Ross, J. S., Jan 17 2017, In : Journal of the American College of Cardiology. 69, 2, p. 244-246 3 p.

Research output: Contribution to journalLetter

2 Scopus citations

Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction

Yao, X., Shah, N. D., Sangaralingham, L. R., Gersh, B. J. & Noseworthy, P., Nov 28 2017, In : Journal of the American College of Cardiology. 70, 21, p. 2734-2735 2 p.

Research output: Contribution to journalLetter

2 Scopus citations
2016

Dabigatran Versus Warfarin in Relation to Renal Function in Patients with Atrial Fibrillation

Munoz, F. D. C., Yao, X., Abraham, N. S., Bellolio, F., Rabinstein, A., Asirvatham, S. J., McBane, R. D., Gersh, B. J., Shah, N. D. & Noseworthy, P., Jul 5 2016, In : Journal of the American College of Cardiology. 68, 1, p. 129-131 3 p.

Research output: Contribution to journalLetter

3 Scopus citations

Inclusion of hypoglycemia in clinical practice guidelines and performance measures in the care of patients with diabetes

Rodriguez-Gutierrez, R., Ospina, N. S., McCoy, R., Lipska, K. J., Shah, N. D. & Montori, V. M., Nov 1 2016, In : JAMA Internal Medicine. 176, 11, p. 1714-1716 3 p.

Research output: Contribution to journalLetter

17 Scopus citations
2014

Response

Haas, L. R., Takahashi, P. Y., Shah, N. D., Stroebel, R. J., Bernard, M. E., Finnie, D. M. & Naessens, J. M., Jul 2014, In : American Journal of Managed Care. 20, 7

Research output: Contribution to journalLetter

Response to Comments on Zhang et al. Second-line agents for glycemic control for type 2 diabetes: Are newer agents better?

Zhang, Y., McCoy, R. G., Mason, J. E., Smith, S. A., Shah, N. D. & Denton, B. T., Sep 2014, In : Diabetes care. 37, 9, p. e206-e207

Research output: Contribution to journalLetter

2011

Rosiglitazone saga: Authors' reply

Montori, V. M. & Shah, N. D., Apr 30 2011, In : BMJ. 342, 7804, d2567.

Research output: Contribution to journalLetter

What is value in health care? [1]

Tilburt, J. C., Montori, V. M. & Shah, N. D., Mar 31 2011, In : New England Journal of Medicine. 364, 13, p. e26.1

Research output: Contribution to journalLetter

9 Scopus citations
2004

Patent expiration for lansoprazole [3]

Vermeulen, L. C., Hoffman, J. M. & Shah, N. D., Nov 1 2004, In : American Journal of Health-System Pharmacy. 61, 21, 1 p.

Research output: Contribution to journalLetter